Detalles de la búsqueda
1.
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity - IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024.
medRxiv;
2024 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38883802
2.
Association between emergency department disposition and mortality in patients with COVID-19 acute respiratory distress syndrome.
J Am Coll Emerg Physicians Open;
5(3): e13192, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38887225
3.
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.
JAMA Netw Open;
7(4): e244954, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38573635
4.
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024.
MMWR Morb Mortal Wkly Rep;
73(8): 180-188, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421945
5.
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
Clin Infect Dis;
78(4): 1056-1064, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38051664
6.
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023.
MMWR Morb Mortal Wkly Rep;
72(40): 1083-1088, 2023 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796753
7.
Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials.
Crit Care Med;
51(12): e269-e274, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37695136
8.
Further advancing emergency department triage prediction.
Resuscitation;
191: 109930, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37748821
9.
Right Ventricular Dysfunction Patterns among Patients with COVID-19 in the Intensive Care Unit: A Retrospective Cohort Analysis.
Ann Am Thorac Soc;
20(10): 1465-1474, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37478340
10.
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Lancet Respir Med;
11(9): 791-803, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37348524
11.
Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022.
Vaccine;
41(29): 4249-4256, 2023 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37301704
12.
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial.
JAMA Netw Open;
6(5): e2314428, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37227729
13.
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
Clin Infect Dis;
77(4): 547-557, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37255285
14.
Association of an Emergency Critical Care Program With Survival and Early Downgrade Among Critically Ill Medical Patients in the Emergency Department.
Crit Care Med;
51(6): 731-741, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37010317
15.
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023.
MMWR Morb Mortal Wkly Rep;
72(17): 463-468, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104244
16.
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.
J Infect Dis;
228(3): 235-244, 2023 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883903
17.
Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness.
JCI Insight;
8(3)2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36752204
18.
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022.
Open Forum Infect Dis;
10(1): ofac698, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695662
19.
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States.
Clin Infect Dis;
76(3): e460-e468, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580849
20.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 18 States, September 8-November 30, 2022.
MMWR Morb Mortal Wkly Rep;
71(5152): 1625-1630, 2022 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36580424